During the last session, Xtant Medical Holdings Inc (AMEX:XTNT)’s traded shares were 0.52 million, with the beta value of the company hitting 0.39. At the end of the trading day, the stock’s price was $0.62, reflecting an intraday loss of -4.80% or -$0.03. The 52-week high for the XTNT share is $1.45, that puts it down -133.87 from that peak though still a striking 3.23% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $80.90M, and the average intraday trading volume over the past 10 days was 67050.0 shares, and the average trade volume was 68.50K shares over the past three months.
Xtant Medical Holdings Inc (XTNT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. XTNT has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Xtant Medical Holdings Inc (AMEX:XTNT) trade information
Xtant Medical Holdings Inc (XTNT) registered a -4.80% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.80% in intraday trading to $0.62, hitting a weekly high. The stock’s 5-day price performance is -7.31%, and it has moved by -5.92% in 30 days. Based on these gigs, the overall price performance for the year is -46.00%. The short interest in Xtant Medical Holdings Inc (AMEX:XTNT) is 0.19 million shares and it means that shorts have 2.81 day(s) to cover.
Xtant Medical Holdings Inc (XTNT) estimates and forecasts
Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -114.30% this quarter and then jump 100.00% in the quarter after that. In the rating firms’ projections, revenue will increase 29.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 29.05M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 32.35M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 25.02M and 28.11M respectively. In this case, analysts expect current quarter sales to grow by 16.10% and then jump by 15.10% in the coming quarter.
While earnings are projected to return -950.00% in 2024, the next five years will return 20.00% per annum.
Xtant Medical Holdings Inc (AMEX:XTNT)’s Major holders
Xtant Medical Holdings Inc insiders own 7.34% of total outstanding shares while institutional holders control 69.21%, with the float percentage being 74.70%. ORBIMED ADVISORS LLC is the largest shareholder of the company, while 35.0 institutions own stock in it. As of 2024-03-31, the company held over 73.11 million shares (or 56.232% of all shares), a total value of $85.54 million in shares.
The next largest institutional holding, with 7.65 million shares, is of ALTIUM CAPITAL MANAGEMENT LP’s that is approximately 5.8819% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $8.95 million.
